In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co (through holdings in Baillie Gifford & Co, and through its wholly owned subsidiary, Baillie Gifford Overseas Limited) has increased its holding of B shares in Novozymes A/S to a total of 25,388,300 B shares of a nominal value of DKK 50,776,600, equivalent to 7.81% of Novozymes A/S’ share capital and 3.14% of the voting rights.
Recommended Reading
-
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Read More -
COPENHAGEN, Denmark – May 5, 2026. In the first quarter of 2026, Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.8%. Ester Baiget, President & CEO: ...
Read More